Creon and Kalydeco drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Creon (pancrelipase (amylase;lipase;protease)) and Kalydeco (ivacaftor). Common drug interactions include frequent bowel movements among females and infective pulmonary exacerbation of cystic fibrosis among males.
The phase IV clinical study analyzes what interactions people have when they take Creon and Kalydeco. It is created by eHealthMe based on reports of 973 people who take the same drugs from the FDA, and is updated regularly.
What is Creon?
Creon has active ingredients of pancrelipase (amylase;lipase;protease). It is often used in pancreatitis. eHealthMe is studying from 29,489 Creon users. Check the latest studies of Creon.
What is Kalydeco?
Kalydeco has active ingredients of ivacaftor. eHealthMe is studying from 6,652 Kalydeco users. Check the latest studies of Kalydeco.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
973 people who take Creon and Kalydeco together, and have interactions are studied.
What are the common drug interactions of Creon and Kalydeco, by gender? *
What are the common drug interactions of Creon and Kalydeco, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Creon and Kalydeco?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Creon and Kalydeco:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Creon:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Kalydeco:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Creon and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Kalydeco and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on pancrelipase (amylase;lipase;protease) and ivacaftor (the active ingredients of Creon and Kalydeco, respectively), and Creon and Kalydeco (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ofev cause Spinal Compression Fracture? - now
- Sulfamethoxazole and Agranulocytosis for Men aged 60+ - now
- Sulfamethoxazole and Neutropenia for Men aged 60+ - a second ago
- Sulfamethoxazole and Granulocytopenia for Men aged 60+ - a second ago
- Sulfamethoxazole and Granulopenia for Men aged 60+ - a second ago
- Could Escitalopram Oxalate cause Urinary Retention? - 3 seconds ago
- Drug interactions of Campath and Morphine - 3 seconds ago
- Levetiracetam and Urinary Incontinence for Men aged 60+ - 6 seconds ago
- Levetiracetam and Bladder Incontinence for Men aged 60+ - 6 seconds ago
- Levetiracetam and Urination - Uncontrollable for Men aged 60+ - 7 seconds ago